Table 5.
Samples | Particle size | ZP ± SEM (mV) | PDI | pH |
---|---|---|---|---|
| ||||
Size ± SEM (d nm) | ||||
Placebo NA-SNEDDSa | 51.56 ± 0.07 | −11.7 ± 1.25 | 0.106 ± 0.02 | 6.56 |
NA-SNEDDS, 0.5% | 34.44 ± 0.16 | 6.76 ± 0.042 | 0.22 ± 0.003 | 4.94 |
NA-SNEDDS, 2% | 38.49 ± 4.30 | 31.7 ± 3.58 | 0.318 ± 0.22 | 5.02 |
Placebo A-SNEDDSb | 29.20 ± 0.173 | −36.2 ± 2.79 | 0.190 ± 0.04 | 8.39 |
A-SNEDDS, 0.5% | 33.79 ± 0.166 | −27.2 ± 1.56 | 0.151 ± 0.01 | 8.49 |
A-SNEDDS, 2% | 35 ± 2.80 | −21.2 ± 3.46 | 0.28 ± 0.06 | 8.41 |
Notes: Data expressed as mean ± standard error of mean (n = 3).
Nonalkalinized self-nanoemulsifying drug-delivery system loaded with 0.5% w/w raloxifene;
alkalinized self-nanoemulsifying drug-delivery system loaded with 0.5% w/w raloxifene.